United Orthopedic Corporation (TPEX:4129)

Market Cap	8.68B +5.1%
Revenue (ttm)	5.85B +19.8%
Net Income	458.98M -17.0%
EPS	4.62 -19.5%
Shares Out	96.44M
PE Ratio	19.49
Forward PE	n/a
Dividend	4.50 (5.00%)
Ex-Dividend Date	Jul 23, 2025

Volume	289,030
Open	90.00
Previous Close	90.00
Day's Range	89.70 - 90.50
52-Week Range	89.20 - 131.50
Beta	0.43
Analysts	Strong Buy
Price Target	137.67 (+52.97%)
Earnings Date	Aug 12, 2026

About United Orthopedic

United Orthopedic Corporation engages in the research, development, manufacture, and sale of orthopedic implants and surgical instruments in Taiwan, Asia, America, Europe, Africa, and Oceania. The company offers artificial hip joints, partial hip joints, joints for large trochanteric fractures, Moore hip prostheses, and customized artificial hip joints for individual tumor patients; artificial knee joints, including artificial knee replacement joints, revision knee replacement systems, restricted artificial knee joints, and customized artificia...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1993
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4129

Financial Performance

In 2025, United Orthopedic's revenue was 5.66 billion, an increase of 21.54% compared to the previous year's 4.65 billion. Earnings were 562.02 million, an increase of 23.14%.